Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice (Q74762830)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220551%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220551%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220551%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220551%20AND%20SRC:MED&resulttype=core&format=json

Cytokine and Growth Factor Reviews

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220551%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220551%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

4-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220551%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

379-391

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220551%20AND%20SRC:MED&resulttype=core&format=json

Interferons and their actions

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

How cells respond to interferons

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Functional role of type I and type II interferons in antiviral defense

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

The neglected role of type I interferon in the T-cell response: implications for its clinical use

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Biologic Effects of Interferons

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

The function of type I interferons in antimicrobial immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Interferon beta in multiple sclerosis: is IL-12 suppression the key?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Type I IFN modulates innate and specific antiviral immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Natural killer cells in antiviral defense: function and regulation by innate cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Altered immune responses in mice lacking inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Expression of CCR-7, MIP-3beta , and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Type I interferons in combination with bacterial stimuli induce apoptosis of monocyte-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

The interferon system and interferon regulatory factor transcription factors -- studies from gene knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Regulation of the natural killer cell receptor repertoire

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Type I interferon-mediated stimulation of T cells by CpG DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

T cell stimulation in vivo by lipopolysaccharide (LPS).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Type I interferons keep activated T cells alive

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Functional diversity of helper T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

1 reference

7 January 2021

Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

IFN-beta differentially regulates CD40-induced cytokine secretion by human dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Regulation of T helper cell differentiation by STAT molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Immune response in Stat2 knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Interferons alpha and beta as immune regulators--a new look

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Interferon-mediated fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Side effects of interferon-alpha in treating hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Psoriasis and alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Psoriasis induced by interferon-α

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Interferon-induced vitiligo in a patient with chronic viral hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Side effects of alpha interferon in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

The type I interferon system is locally activated in psoriatic lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Treatment of primary Sjögren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosal route: a phase II clinical trial. IFN Protocol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Resident bone marrow macrophages produce type 1 interferons that can selectively inhibit interleukin-7-driven growth of B lineage cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Induction of type I diabetes by interferon-alpha in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Evidence from Transgenic Mice That Interferon-β May Be Involved in the Onset of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

The ability of bacterial lipopolysaccharide to modulate the induction of unresponsiveness to a state of immunity. Cellular parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Lipopolysaccharide interferes with the induction of peripheral T cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

IRF family of transcription factors as regulators of host defense

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Multistage regulation of Th1-type immune responses by the transcription factor IRF-1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Erratum: Requirement for IRF-1 in the microenvironment supporting development of natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Requirement for transcription factor IRF-1 in NO synthase induction in macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

ISGF3 gamma p48, a specificity switch for interferon activated transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Interferon regulatory factors: the next generation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Interferon regulatory factor-2 is a transcriptional activator in muscle where It regulates expression of vascular cell adhesion molecule-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Interferon regulatory factor-2 directs transcription from the gp91phox promoter

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Inducible processing of interferon regulatory factor-2

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Gene repression by coactivator repulsion

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Coactivator p300 acetylates the interferon regulatory factor-2 in U937 cells following phorbol ester treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Interferon regulatory factors and TFIIB cooperatively regulate interferon-responsive promoter activity in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Interleukin-12 induces expression of interferon regulatory factor-1 via signal transducer and activator of transcription-4 in human T helper type 1 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

The physiological interferon response

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Animal models of psoriasis - what can we learn from them?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

A macrophage LPS-inducible early gene encodes the murine homologue of IP-10.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Mutation and association analysis of the interferon regulatory factor 2 gene (IRF2) with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Strain Dependence of the Antiproliferative Action of Interferon on Murine Erythroid Precursors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

Strain Differences in Production of Murine Interferons

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6101%2802%2900023-0

7 January 2021

10.1016/S1359-6101(02)00023-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12220551%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference